Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: J Orthop Res. 2012 May 22;30(11):1725–1731. doi: 10.1002/jor.22149

Table 2.

Gene expression current study: Normalized copy number, ln transformed, mean and std dev for the 26 genes compared between shoulder and body wall implantation sites at 28 days.

GENE 28 Day Gene Expression
Category Name Abbr. Shoulder Xenograft
Mean (SD)
Body Wall Xenograft
Mean (SD)
Pro-inflammatory Interleukin-1α IL-1α −8.66(4.51) −9.50(4.34)
Interleukin-1β IL-1β −6.93(3.49) −7.24(4.15)
Interleukin-6 IL-6 −11.12(3.61) −12.11(3.40)
Interleukin-8 IL-8 −13.99(3.40) −15.13(2.41)
Interleukin-12β IL-12β −10.25(3.08) −9.90(3.02)
Interleukin-18 IL-18 −7.02(4.55) −6.80(4.16)
Interferon-γ INFγ −13.19(4.25) −12.78(6.32)
inducible Nitric Oxide Synthase iNOS −6.81(3.30) −6.51(3.48)
Tumor Necrosis Factor-α TNFα −10.13(4.86) −9.73(2.58)
Pro-remodeling Arginase ARG −13.96(3.12) −14.11(3.07)
Interleukin-1 receptor antagonist IL-1ra −5.52(2.86) −4.85(3.64)
Interleukin-4 IL-4 −12.83(4.11) −12.97(4.29)
Interleukin-5 IL-5 −18.21(4.80) −17.06(3.87)
Interleukin-10 IL-10 −12.18(3.23) −12.24(2.86)
Interleukin-13 IL-13 −13.00(3.32) −12.58(3.40)
Transforming Growth Factor-β TGF-β −6.89(3.54) −7.01(2.83)
ECM/Tendon Decorin DEC −3.40(3.96) −3.50(3.87)
Collagen Type I Col I 1.18(3.72) 0.15(3.92)
Collagen Type III Col III −8.09(3.84) −7.95(3.35)
Thrombospondin-4 TSP4 −11.42(3.27) −11.27(3.12)
Scleraxis SCX −10.36(3.99) −11.54(4.36)
Tenomodulin TND −7.51(5.20) −8.44(5.30)
Enzyme Cathepsin K Cat K −6.33(3.87) −4.85(4.54)
Matrix Metalloproteinase-2 MMP2 −10.37(4.26) −10.55(4.49)
Matrix Metalloproteinase-3 MMP3 −6.95(3.97) −7.07(3.96)
Matrix Metalloproteinase-13 MMP13 −5.59(2.93) −5.74(3.81)